123 related articles for article (PubMed ID: 9833191)
21. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas.
Stoll C; Baretton G; Soost F; Terpe HJ; Domide P; Löhrs U
Oral Oncol; 1999 Sep; 35(5):484-9. PubMed ID: 10694948
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
[TBL] [Abstract][Full Text] [Related]
23. CD44 expression in soft tissue sarcomas.
Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H
Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171
[TBL] [Abstract][Full Text] [Related]
24. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
26. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD44 splice variants in human skin and epidermal tumours.
Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma.
Harn HJ; Ho LI; Shyu RY; Yuan JS; Lin FG; Young TH; Liu CA; Tang HS; Lee WH
J Clin Gastroenterol; 1996 Mar; 22(2):107-10. PubMed ID: 8742647
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of CD44 variant expression in primary breast cancer.
Foekens JA; Dall P; Klijn JG; Skroch-Angel P; Claassen CJ; Look MP; Ponta H; Van Putten WL; Herrlich P; Henzen-Logmans SC
Int J Cancer; 1999 Jun; 84(3):209-15. PubMed ID: 10371335
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
31. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
32. Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.
Berner HS; Nesland JM
Breast Cancer Res Treat; 2001 Jan; 65(1):23-9. PubMed ID: 11245336
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of immunohistochemical expression of beta-1 integrin in pancreatic carcinoma.
Böttger TC; Maschek H; Lobo M; Gottwohl RG; Brenner W; Junginger T
Oncology; 1999; 56(4):308-13. PubMed ID: 10343195
[TBL] [Abstract][Full Text] [Related]
34. [CD44 splice variants as prognostic factors in invasive cervix carcinoma].
Reinthaller A; Kainz C; Kohlberger P; Tempfer C; Gitsch G; Kölbl H; Breitenecker G
Gynakol Geburtshilfliche Rundsch; 1995; 35(1):16-9. PubMed ID: 7537136
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]